04633cam a2200673Ia 4500 ocn694733434 OCoLC 20171023122232.0 m o d cr cn||||||||| 110103s2011 nyua ob 001 0 eng d 9781441972163 (electronic bk.) 1441972161 (electronic bk.) 9781441972156 (electronic bk.) 1441972153 (electronic bk.) AU@ 000048771752 AU@ 000049595547 DEBSZ 430928793 GBVCP 790038005 NZ1 13777845 NZ1 15921957 DEBBG BV043392620 (OCoLC)694733434 (OCoLC)698589443 (OCoLC)748435289 (OCoLC)771448200 (OCoLC)798698956 978-1-4419-7215-6 Springer http://www.springerlink.com GW5XE eng pn GW5XE EBLCP OCLCQ MHW OCLCQ OCLCF OCLCQ E7B N$T RRP OCLCO YDXCP DEBSZ OCLCO DG1 OCLCO OCLCQ OCLCO OCLCQ DEBBG DG1 MAIN RC280.O8 E44 2011 2011 B-194 WP 322 (S HEA 039030 bisacsh MED 062000 bisacsh 616.99/465 22 Emerging therapeutic targets in ovarian cancer / Stan Kaye [and others], editors. [electronic resource] New York : Springer Science+Business Media, LLC, ©2011. 1 online resource (xiii, 291 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references and index. Preface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer. This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers. Print version record. Ovaries Cancer Treatment. Ovarian Neoplasms therapy. Antineoplastic Agents therapeutic use. Drug Design. Drug Therapy trends. Medicine. HEALTH & FITNESS Diseases Cancer. bisacsh MEDICAL Oncology. bisacsh Ovaries Cancer Treatment. fast (OCoLC)fst01049287 Electronic books. Kaye, Stanley B. Print version: Emerging therapeutic targets in ovarian cancer. New York : Springer, ©2011 9781441972156 (OCoLC)702604723 http://onlinelibrary.wiley.com/book/10.1002/9781118185537 Wiley Online Library 505-00/(S Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs / Susana Banerjee, Michael A. Bookman, and Martin Gore -- Discovery of Novel Targets / John Farley and Michael J. Birrer -- Novel Anti-angiogenic Therapies in Ovarian Cancer / Jurjees Hasan and Gordon Jayson -- Targeting the AKT Pathway in Ovarian Cancer / Euan A. Stronach [and others] -- Inhibition of the Src Oncogene : Therapeutic Potential in Ovarian Carcinoma / Liz Y. Han and Anil K. Sood -- Tumour-Specific Synthetic Lethality : Targeting BRCA Dysfunction in Ovarian Cancer / Timothy A. Yap [and others] -- Targeting Inflammatory Pathways in Epithelial Ovarian Cancer / Jermaine Coward and Frances Balkwill -- Epithelial-to-Mesenchymal Transition and Cellular Membrane Receptors in Ovarian Cancer : Moving Forward in the Era of Molecularly Targeted Therapy / Lainie P. Martin, Julia J. Perkins, and Russell J. Schilder -- Epigenetic Therapies / Robert Brown, Nadine Chapman-Rothe, and Ros Glasspool -- Ovarian Cancer Immunology and Immunotherapy / Sadaf Ghaem-Maghami and Martin Gore -- Ovarian Cancer Progenitor/Stem Cells: Therapeutic Potential / Susan K. Murphy and Andrew Berchuck -- Potential for α-Folate Receptor-Targeted Treatment for Ovarian Cancer / Chau H.M. Ng and Ann L. Jackman -- New Insights into Tubulin Binders / Carles Escriu and James D. Brenton. ddc BK 208322 208322